Immutep
IMMP
$2.25
Share price
2.27%
Change (1 day)
43.31%
Change (1 year)
Categories
Immutep (IMMP) - Cash on Hand
Cash on Hand as of June 2023 : $81.69 M
According to Immutep's latest financial reports the company has $81.69 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Immutep - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-06-30 | $81.69 M | 48.43% |
| 2022-06-30 | $55.04 M | 21.83% |
| 2021-06-30 | $45.17 M | 149.76% |
| 2020-06-30 | $18.08 M | 55.45% |
| 2019-06-30 | $11.63 M | -33% |
| 2018-06-30 | $17.36 M | 84.69% |
| 2017-06-30 | $9.4 M | -39.7% |
| 2016-06-30 | $15.59 M | 200.72% |
| 2015-06-30 | $5.18 M | -76.26% |
| 2014-06-30 | $21.84 M | -20.29% |
| 2013-06-30 | $27.4 M | -29.63% |
| 2012-06-30 | $38.94 M | -34.88% |
| 2011-06-30 | $59.8 M | 354.48% |
| 2010-06-30 | $13.15 M | 1505.01% |
| 2009-06-30 | $0.81 M | -22.85% |
| 2008-06-30 | $1.06 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | $1.05 B | 1,190.10% | 🇺🇸 USA |
 FibroGen FGEN | $0.23 B | 188.36% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | $6.56 M | -91.97% | 🇺🇸 USA |